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Vascular pathologyHippocampal sclerosis is themost frequent pathology encountered in resected tissue obtained frompatientswith
temporal lobe epilepsy. The main hallmarks of hippocampal sclerosis are neuronal loss and gliosis. Several au-
thors have proposed that an increase in blood vessel density is a further indicator, based on interpretations
from staining of markers related to both blood–brain barrier disruption and the formation of new blood vessels.
However, previous studies performed in our laboratory using correlative light and electron microscopy revealed
that many of these “blood vessels” are in fact atrophic vascular structures with a reduced or virtually absent
lumen and are often ﬁlled with processes of reactive astrocytes. Thus, “normal” vasculature within the sclerotic
CA1 ﬁeld is drastically reduced. Since this decrease is consistently observed in the human sclerotic CA1, this fea-
ture can be considered another key pathological indicator of hippocampal sclerosis associatedwith temporal lobe
epilepsy.
This article is part of a Special Issue entitled “NEWroscience 2013”.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Temporal lobe epilepsy (TLE) is a common form of intractable epi-
lepsy, and hippocampal sclerosis is the most frequent pathology en-
countered in resected mesial temporal tissue obtained from patients
with TLE [1]. In general, hippocampal sclerosis is characterized by gliosis
and neuronal loss, most prominently in the CA1 ﬁeld, followed by the
CA3 and CA2 ﬁelds, and the dentate gyrus [1,2]. These alterations are
commonly accompanied by a dispersion of the dentate granular cell
layer, with ectopic neurons appearing in the molecular layer [3]. There
are also changes in the expression of a variety of molecules in the sur-
viving cells, as well as axonal reorganization involving both excitatory
and inhibitory circuits [e.g., 4–12].
Early studies on hippocampal sclerosis performed at the end of the
XIXth-century, such as those conducted by Sommer [13] and Bratz
[14], also described vascular alterations in the sclerotic regions, and it
was suggested that these alterations contribute to epileptogenicity.mmonis; Collagen-IV, collagen
Vv, volume fraction.
. Doctor Arce 37, 28002 Madrid,
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ghts reserved.However, neuropathological analysis has mainly focused on the loss of
neurons and gliosis. In recent years, there has been renewed interest in
the study of vasculature alterations. For example, studies on sclerotic
hippocampal tissue have reported changes in the permeability of the
blood–brain barrier (BBB), with this disruption being proposed as a
trigger for epileptiform activity [15–21, for a review, see 22]. It has
been proposed that inﬂammatory processes are activated if normal
BBB permeability is disrupted [23], thereby damaging the adjacent
brain tissue, producing ion imbalances, and inducing cell death [24].
In addition, an increase in the density of blood vessels in the sclerotic
hippocampus of patients with TLE has been reported [25–27; reviewed
in 28], which is in line with the activation of expression of angiogenic
factors observed in animal models after electroconvulsive seizures
[29]. However, other studies on themicrovasculature of sclerotic hippo-
campal tissue obtained frompatientswith epilepsy by surgical resection
have found an impressive reduction in the blood vessels and a variety of
alterations in the microanatomy of the remaining blood vessels [30].
In this review, we will discuss the controversy surrounding angio-
genesis in the human sclerotic hippocampus and its relationship to
epileptogenicity.
2. Study of the microvasculature in hippocampal sclerosis
Brain microvasculature can be histologically analyzed by numerous
approaches, including histochemical and immunocytochemicalmethods,
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some of their components.
Histochemical methods have been applied, such as the detection
of NADPH–diaphorase activity, which is an enzyme located in the en-
dotheliumwhose staining is reduced in epilepsy animal models [31].
Staining of the endogenous enzyme alkaline phosphatase (AP) has
been widely used (reviewed in [32]). Alkaline phosphatase is an en-
zyme present in the endothelial cells of the BBB, and it has been used
to visualize the capillary network of the cerebral cortex and subcor-
tical structures [33–36]. In particular, AP staining labeled numerous
blood vessels in all ﬁelds of the normal hippocampal formation,
and a signiﬁcant decrease in the density of AP-positive blood vessels
has been described in the CA1 of the sclerotic hippocampus [30]. It
has also been shown that AP activity varies in the rat brain when sei-
zures are induced [37]. Furthermore, uniform AP staining was ob-
served in all hippocampal ﬁelds of patients with nonsclerotic
epilepsy, suggesting that the changes in AP activity are speciﬁcally
related to hippocampal sclerosis and not to epileptic activity per se
[30]. Moreover, genetic defects in AP lead to epileptic seizures due
to alterations in the normal AP activity [38–42], which has been hy-
pothesized to be due to the inability of AP to regulate GABA synthesis
and neurotransmission in the cerebral cortex [43,44]. Thus, the re-
duction of AP staining would suggest a modiﬁcation in its activity,
and this might in turn imply alterations to the GABAergic system.
Such alterations have been proposed as being responsible for the de-
velopment of TLE [reviewed in 45–47].
The detection of plasma components outside the blood vessels has
been used as an indicator of BBB disruption related to epileptogenicity
[20,25,48]. For example, it has been described that vascular endothelial
growth factor (VEGF) is upregulated in pathological conditions of the
brain tissue, including seizures, and that this growth factor promotes
BBB disruption and formation of new microvessels [25, reviewed in
27,49].Fig. 1. Low-power photomicrographs of collagen-IV immunostained hippocampal
sections from control (A) and sclerotic hippocampus (B) to illustrate the distribution of
collagen-IV-ir blood vessels. Arrows indicate the CA1 areas also shown at a higher magni-
ﬁcation in Figs. 2A and B. C: Photomicrograph of Nissl-stained section showing the hippo-
campal formation from a patient with sclerotic epilepsy. Note that the sclerotic
hippocampal formation is smaller than the control hippocampus. Sub: subiculum. Scale
bar (in C): 1000 μm.3. Angiogenesis or vascular reduction?
In recent years, a number of laboratories have described an in-
crease in the number of blood vessels in both patients with epilepsy
and animal models, using markers related to angiogenesis [reviewed
in 27,49].
Studies performed using collagen type IV (collagen-IV) immuno-
reactivity (-ir) in the sclerotic hippocampus of patients with epilepsy
showed a signiﬁcantly higher density (increase of 160%) in the CA1
ﬁeld when compared with the nonsclerotic hippocampus [30].
Collagen-IV is an essential component of the basal lamina in terms
of maintaining the endothelial permeability barrier, and it is present
in most blood vessel types [50]. Collagen-IV-ir has been largely used
to study the microvascular network in several brain disorders
[51–54].
It seems clear that the higher density of positive collagen-IV-ir ele-
ments in the sclerotic hippocampus suggests that angiogenesis has oc-
curred. This would be in keeping with studies using immunostaining
for VEGFwhich have reported an increase in blood vessel density in pa-
tients with TLE [25,27].
However, we observed that closer examination of the collagen-IV-ir
elements revealed that in the stratum pyramidale of the CA1 ﬁeld from
the sclerotic hippocampi, many of the collagen-IV-ir blood vessels were
notably altered (Figs. 1–3). These blood vessels had a rough surfacewith
numerous small, spine-like protrusions compared with the typically
smooth surface found in the nonsclerotic CA1. These protrusions gave
a “spiny” appearance to the surface of the blood vessels. Furthermore,
the most notable alteration was that instead of the homogeneous
staining of the blood vessel surface, numerous abnormal tubular or
“vascular-like” structures appeared with a vacuolar or reticulated ap-
pearance [30].Therefore, we used correlative light and electron microscope
(EM) techniques to analyze these collagen-IV-ir elements in the
sclerotic CA1. These correlative light and EM methods allowed the
unequivocal identiﬁcation of blood vessels and its ultrastructure.
The surface of many blood vessels displayed abnormal protrusions
of the basal lamina that were responsible for the “spiny” appearance
of the blood vessels in this region (Fig. 2,3). Interestingly, the
vascular-like collagen-IV-ir processes with a vacuolar appearance
were indeed atrophic branches of blood vessels with the peculiarity
that their reduced lumen was mainly ﬁlled with the processes of re-
active astrocytes. The nature of these structures suggested collapse
of the blood vessels in the CA1 ﬁeld of the sclerotic hippocampus
[30].
Remarkably, these altered blood vessels were mainly found
in those areas where neuronal loss was so severe that virtually no
Fig. 2. Photomicrographs of the CA1 ﬁeld froma control (A) and sclerotic (B) hippocampus illustrating the apparent increase in collagen-IV-ir blood vessels in the sclerotic tissue. C:Higher
magniﬁcation to illustrate the smooth surface of the collagen-IV-ir blood vessels in the control tissue. D: Higher magniﬁcation to illustrate the presence of small spine-like protrusions on
the surface of the collagen-IV-ir blood vessel (arrowheads). E: Highermagniﬁcation to show the abnormal tubular or “vascular-like” collagen-IV-ir structureswith a vacuolar or reticulated
appearance. Scale bar (in E): 75 μm in A, B and 10 μm in C–E.
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blood vessels are closely coupled, both anatomically and functional-
ly [reviewed in 56–58]. Indeed, neurons, glia, and blood vessels
have been considered together as a functional entity called the
neurovascular unit [24]. This is in line with the fact that perturba-
tions in the integrity of neurovascular function are thought to initi-
ate several cascades associated with injury, which may damage the
adjacent brain tissue, producing ion imbalances and inducing cell
death [24].
In order to conﬁrm these observations, we used plastic semithin
sections (2–5 μm thick) stained with toluidine blue (Fig. 4). This
method allows the visualization not only of neurons and glia but
also of blood vessels, regardless of their possible molecular alter-
ations. We estimated the volume fraction (Vv) occupied by blood
vessels in the sclerotic CA1 ﬁeld where immunostaining for
collagen-IV appeared to show an increase of blood vessels. We ob-
served a signiﬁcant decrease in the volume occupied by blood vessels
in the CA1 ﬁeld (approximately 60%) compared with nonsclerotic
tissue [30], conﬁrming that many of the structures that had been
interpreted as blood vessels in the preparations immunostained for
collagen-IV were in fact fragments resulting from degenerating of
blood vessels.
Finally, it should be noted that the signiﬁcance of the local reduction
of blood vessels is not clear. In order to deﬁne the functional signiﬁcance
of speciﬁc changes in themicrovascular network of patients with TLE, it
will be necessary to perform electrophysiological studies in conjunction
with correlative microanatomical and neurochemical characterization
of the epileptic tissue.4. Conclusions
Angiogenesis in the sclerotic hippocampus has been proposed previ-
ously, based on the apparent increase in blood vessel density, presumed
from staining of markers related to BBB disruption and formation
of new blood vessels (such as VEGF). However, correlative light and
electron microscopy reveals that many of these “blood vessels” are in
fact atrophic vascular structures with a reduced or virtually absent
lumen and are often ﬁlled with processes of reactive astrocytes. Thus,
“normal” blood vessels within the sclerotic CA1 are drastically reduced
as conﬁrmed by volume fraction analysis in semithin section (which
showed a 60% reduction). It is striking that this kind of relatively simple
and powerful analysis had gone unnoticed in previous histopathological
assessment of the sclerotic hippocampus. Since this decrease is consis-
tently observed in the human sclerotic CA1, this feature can be consid-
ered as another histopathological hallmark of hippocampal sclerosis.Acknowledgments
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Fig. 4. Photomicrograph of semithin sections (2 μm) stainedwith 1% toluidine blue, from control (A) and sclerotic (B) CA1 ﬁeld to illustrate the Cavalieri method used to estimate the Vv of
blood vessels. Note the presence of abundant pyramidal cells and blood vessels in the nonsclerotic CA1 (A)when comparedwith the sclerotic tissue (B). A grid of small intersections over-
lying the tissue is displayed. Adjacent grid points are 20 μmapart, providing an area enclosed by any 4 given grid points of 400 μm2 (20 × 20). Yellow asterisks indicate the intersections in
the grid that lies within blood vessels (n = 5, 5 × 400 = 2000 μm2 in nonsclerotic and n = 1, 400 μm2 in sclerotic). Note that the number of intersections (yellow asterisks) in the grid
that lies within the blood vessels is higher in the control tissue than in the sclerotic tissue. Scale bar (in B): 20 μm.
Fig. 3. Correlative light and electronmicroscopy photomicrographs of a collagen-IV-ir blood vessel in the CA1 ﬁeld of a sclerotic hippocampus. A: Photomicrograph of a plastic-embedded
section showing collagen-IV-ir blood vessels. B: Photomicrograph of a 2-um-thick semithin plastic section obtained from the same section shown in A. V1 and V2 indicate the same blood
vessels labeled in A. C: Low-power electron micrograph taken after the resection of the semithin section shown in B illustrating blood vessel V1. The arrow and arrowhead indicate small
spine-like protrusions on the surface of the collagen-IV-ir blood vessel and an atrophic branch, respectively. D, E: Highermagniﬁcation of C to illustrate themorphological alterations to the
blood vessel V1. Arrow in D indicates the same protrusion as in C. E is a higher magniﬁcation of the atrophic branch in the blood vessel, which appears as an abnormal protrusion of the
endothelial membrane. Scale bar (in E): 150 μm in A, 75 μm in B, 10 μm in C, 2.5 μm in D, and 1 μm in E.
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